Patent 11781177 was granted and assigned to Pacific Biosciences on October, 2023 by the United States Patent and Trademark Office.
Compositions comprising covalently modified and mutated biotin-binding proteins, particularly biotin-binding proteins having a negative charge at physiological pH, are provided. Methods of producing such proteins are also provided, as are methods of immobilizing, sequencing, and making nucleic acids employing such proteins.